Trevi Therapeutics (TRVI) to Release Quarterly Earnings on Tuesday
Chronological Source Flow
Back
AI Fusion Summary
Trevi Therapeutics (NASDAQ:TRVI) will announce its Q4 2025 earnings on Tuesday, March 17, with analysts projecting a loss of $0.10 per share. HC Wainwright has reiterated a buy rating, setting a $21.00 price objective. D. Boral Capital also reaffirmed a buy rating, citing a $19.00 target, while other analysts have issued similar reports.
Comments